Andrew Kirschner
Family Medicine · Bala Cynwyd, PANPI 1710927306
Payments from drug & device makers
Across 115 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$852
- Braeburn Inc.$209
- Kowa Pharmaceuticals America, Inc.$127
- Indivior Inc.$108
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$98
- Biohaven Pharmaceutical Holding Company Ltd.$96
- plus $708 from 17 others
What the payments were for
- Food & beverage$2,198100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $852 |
| Braeburn Inc. | 8 | $209 |
| Kowa Pharmaceuticals America, Inc. | 9 | $127 |
| Indivior Inc. | 6 | $108 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $98 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $96 |
| Pear Therapeutics (US), Inc. | 2 | $95 |
| Pfizer | 5 | $94 |
| Lilly USA, LLC | 4 | $84 |
| Biohaven Pharmaceuticals, Inc. | 4 | $76 |
| Kaleo, Inc. | 3 | $61 |
| Bausch Health US, LLC | 3 | $47 |
| Alkermes, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Bayer | 2 | $29 |
| Astellas Pharma US Inc | 1 | $26 |
| Abbott | 1 | $21 |
| Genentech USA, Inc. | 1 | $21 |
| Electronic Waveform Lab, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Qiagen, LLC | 1 | $15 |
| Gilead | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,198 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 188 | $10,159 |
| VyvanseLisdexamfetamine Dimesylate | 28 | $9,913 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,132 |
| FarxigaDapagliflozin Propanediol | 13 | $7,089 |
| XareltoRivaroxaban | 12 | $6,374 |
| Buprenorphine | 20 | $2,358 |
| Buprenorphine Hcl | 34 | $1,380 |
| Dofetilide | 12 | $1,179 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $630 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $500 |
| Gabapentin | 43 | $484 |
| Clonazepam | 38 | $354 |
| Oxycodone Hcl | 12 | $322 |
| Lisinopril | 47 | $309 |
| Lorazepam | 21 | $236 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bala Cynwyd
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.